Endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis

Oncology Reports

Volumn 22, Issue 5, 2009, Pages 1093-1100

  Jayasinghe, Caren ^a   Simiantonaki, N ^a   Michel Schmidt, R ^a   Kirkpatrick, C J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Colorectal cancer; Hematogenous metastasis; Lymphogenous metastasis; Microvasculature; Vascular endothelial growth factor receptor 3

Indexed keywords

CD31 ANTIGEN; MONOCLONAL ANTIBODY D2-40; OXYGEN; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CELL HYPOXIA; CELL LEVEL; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOGENOUS METASTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VASCULARIZATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELL HYPOXIA; COLON; COLORECTAL NEOPLASMS; ENDOTHELIUM, LYMPHATIC; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 70449354879     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000541     Document Type: Article

References (30)

1. Kopfstein L and Christofori G: Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 63: 449-468, 2006.
2. Langley RR and Fidler IJ: Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28: 297-321, 2007.
3. Alitalo K and Carmeliet P: Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1: 219-227, 2002.
4. Shayan R, Achen MG and Stacker SA: Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 27: 1729-1738, 2006.
5. Tobler NE and Detmar M: Tumor and lymph node lymphangiogenesis - impact on cancer metastasis. J Leukoc Biol 80: 691-696, 2006.
6. Wong SY and Hynes RO: Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5: 812-817, 2006.
7. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M and Alitalo K: Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566-3570, 1995.
8. Kubo H, Fujiwara T, Jussila L, Hashi H, Ogawa M, Shimizu K, Awane M, Sakai Y, Takabayashi A, Alitalo K, Yamaoka Y and Nishikawa SI: Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96: 546-553, 2000.
9. Tammela T, Zarkada G, Wallgard E, Murtomäki A, Suchting S, Wirzenius M, Waltari M, Hellström M, Schomber T, Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Ylä-Herttuala S, Shibuya M, Pytowski B, Eichmann A, Betsholtz C and Alitalo K: Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454: 656-660, 2008.
10. George ML, Tutton MG, Janssen F, Arnaout A, Abulafi AM, Eccles SA and Swift RI: VEGF-A, VEGF-C and VEGF-D in colorectal cancer progression. Neoplasia 3: 420-427, 2001.
11. Witmer AN, van Blijswijk BC, Dai J, Hofman P, Partanen TA, Vrensen GF and Schlingemann RO: VEGFR-3 in adult angiogenesis. J Pathol 195: 490-497, 2001.
12. Clarijs R, Schalkwijk L, Hofmann UB, Ruiter DJ and de Waal RM: Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res 62: 7059-7065, 2002.
13. White JD, Hewett PW, Kosuge D, McCulloch T, Enholm BC, Carmichael J and Murray JC: Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 62: 1669-1675, 2002.
14. Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kuroda T and Chayama K: Regulation of vascular endothelial growth factor (VEGF)-C and VEGF-D expression by the organ microenvironment in human colon carcinoma. Eur J Cancer 40: 1604-1609, 2004.
15. Simiantonaki N, Jayasinghe C and Kirkpatrick CJ: Effect of pro-inflammatory stimuli on tumor cell-mediated induction of endothelial cell adhesion molecules in vitro. Exp Mol Pathol 73: 46-53, 2002.
16. Jayasinghe C, Simiantonaki N, Michel-Schmidt R and Kirkpatrick CJ: Comparative study of human colonic tumor-derived endothelial cells (HCTEC) andnormal colonic microvascular endothelial cells (HCMEC): Hypoxia-induced sVEGFR-1 and sVEGFR-2 levels. Oncol Rep 21: 933-939, 2009.
17. Sobin LH and Wittekind C (ed): International Union Against Cancer (UICC). TNM Classification of Malignant Tumors, fifth edition, 1997.
18. Aparicio S, Sawant S, Lara N, Barnstable CJ and Tombran-Tink J: Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF. Biochem Biophys Res Commun 326: 387-394, 2005.
19. Chen F, Takenaka K, Ogawa E, Yanagihara K, Otake Y, Wada H and Tanaka F: Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer. Clin Cancer Res 10: 8548-8553, 2004.
20. Niki T, Iba S, Yamada T, Matsuno Y, Enholm B and Hirohashi S: Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma. J Pathol 193: 450-457, 2001.
21. Zeng Y, Opeskin K, Baldwin ME, Horvath LG, Achen MG, Stacker SA, Sutherland RL and Williams ED: Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin Cancer Res 10: 5137-5144, 2004.
22. Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I and Kakudo K: Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Clin Cancer Res 9: 5313-5317, 2003.
23. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL and Jain RK: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296: 1883-1886, 2002.
24. Leu AJ, Berk DA, Lymboussaki A, Alitalo K and Jain RK: Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60: 4324-4327, 2000.
25. Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Sakamoto A, Sakamoto T, Maruyama H, Sato S, Mizunuma H and Smith SK: Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res 9: 1361-1369, 2003.
26. Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Umemoto M, Sakamoto T, Sato S, Mizunuma H and Smith SK: Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 88: 237-244, 2003.
27. Zeng Y, Opeskin K, Horvath LG, Sutherland RL and Williams ED: Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 65: 222-230, 2005.
28. Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R and Horvat R: Austrian breast and colorectal cancer study group. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240: 306-312, 2004.
29. Valtola R, Salven P, Heikkilä P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, de Waal R and Alitalo K: VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154: 1381-1390, 1999.
30. Paavonen K, Puolakkainen P, Jussila L, Jahkola T and Alitalo K: Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156: 1499-1504, 2000.